Exercise Performance and Quality of Life of Left Ventricular Assist Device Patients After Long-Term Outpatient Cardiac Rehabilitation

PURPOSE Exercise performance and quality of life (QoL) of left ventricular assist device (LVAD) patients improve after early cardiac rehabilitation (CR). The purpose of this study was to examine the efficacy of multiprofessional long term phase 3 outpatient CR, and whether cardiopulmonary exercise testing (CPX) and 6-min walk testing (6MWT) post-LVAD implantation predict hospital readmission. METHODS This retrospective observational cohort study included 29 LVAD patients (58.6 ± 7.7 yr, female: 13.8%, body mass index: 29.4 ± 3.3 kg/m2). Functional performance tests (CPX, 6MWT, sit-to-stand test), QoL, and psychological surveys (Kansas City Cardiomyopathy Questionnaire, hospital anxiety and depression scale, and Control Convictions about Disease and Health [KKG]) were performed at baseline and at the end of CR. RESULTS The CR was initiated at a median (IQR) of 159 (130-260) d after LVAD implantation for a duration of 340 (180-363) d with 46.8 ± 23.2 trainings. The 6MWT (408.4 ± 113.3 vs 455.4 ± 115.5 m, P = .003) and sit-to-stand test (16.7 ± 6.9 vs 19.0 ± 5.3 repetitions, P = .033) improved, but relative peak oxygen uptake (V˙o2peak: 9.4 [8.2-14.4] vs 9.3 [7.8-13.4] mL/min/kg, P = .57) did not change. Using receiver operating characteristic curve analysis, baseline V˙o2peak values were associated with readmission 1-yr after CR onset (C-statistic = 0.88) with a cutoff value of V˙o2peak < 9.15 mL/min/kg (100% sensitivity, 78% specificity, P < .001). The Kansas City Cardiomyopathy Questionnaire self-efficacy and knowledge (+6.3 points), QoL (+5.0 points), and social limitation (+7.1 points) demonstrated clinically important changes. In addition, the hospital anxiety and depression scale showed a significant reduction in anxiety (4.6 ± 3.2 vs 2.6 ± 2.4, P = .03). CONCLUSIONS Long-term CR is safe and LVAD outpatients showed improvement of QoL, anxiety, and submaximal exercise performance. In addition, V˙o2peak and 6MWT have prognostic value for readmission.

[1]  S. Russell,et al.  Prognostic Value of Peak Oxygen Uptake in Patients Supported With Left Ventricular Assist Devices (PRO-VAD). , 2021, JACC. Heart failure.

[2]  R. Kornowski,et al.  Health‐related quality of life in left ventricular assist device‐supported patients , 2021, ESC heart failure.

[3]  Christopher S. Lee,et al.  Health-Related Quality of Life in Patients With a Left Ventricular Assist Device (QOLVAD) Questionnaire: Initial Psychometrics of a New Instrument. , 2020, The Journal of cardiovascular nursing.

[4]  J. Spertus,et al.  Interpreting the Kansas City Cardiomyopathy Questionnaire in Clinical Trials and Clinical Care: JACC State-of-the-Art Review. , 2020, Journal of the American College of Cardiology.

[5]  R. Buys,et al.  Limiting factors of peak and submaximal exercise capacity in LVAD patients , 2020, PloS one.

[6]  D. Zimpfer,et al.  Hemodynamic exercise responses with a continuous-flow left ventricular assist device: Comparison of patients’ response and cardiorespiratory simulations , 2020, PloS one.

[7]  F. Gustafsson,et al.  Determinants of Functional Capacity and Quality of Life After Implantation of a Durable Left Ventricular Assist Device , 2020, Cardiac failure review.

[8]  D. Zimpfer,et al.  LVAD speed increase during exercise, which patients would benefit the most? A simulation study. , 2020, Artificial organs.

[9]  M. Hannan,et al.  2019 EACTS Expert Consensus on long-term mechanical circulatory support , 2019, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[10]  M. Walsh,et al.  A Fully Magnetically Levitated Left Ventricular Assist Device — Final Report , 2019, The New England journal of medicine.

[11]  D. Zimpfer,et al.  LVAD Pump Flow Does Not Adequately Increase With Exercise , 2018, Artificial organs.

[12]  Mohammad Garakyaraghi,et al.  Beneficial effects of the treatment of iron deficiency on clinical condition, left ventricular function, and quality of life in patients with chronic heart failure , 2018, Acta bio-medica : Atenei Parmensis.

[13]  Emily E Adams,et al.  Quality of life with an LVAD: A misunderstood concept , 2018, Heart & lung : the journal of critical care.

[14]  A. Bayés‐Genís,et al.  Sacubitril/valsartan and short-term changes in the 6-minute walk test: A pilot study. , 2018, International journal of cardiology.

[15]  Mark A Williams,et al.  Cardiac Rehabilitation in Patients With Left Ventricular Assist Device: A SYSTEMATIC REVIEW AND META-ANALYSIS , 2017, Journal of cardiopulmonary rehabilitation and prevention.

[16]  P. Gourraud,et al.  The validation of the sit-to-stand test for COPD patients , 2017, European Respiratory Journal.

[17]  D. Zimpfer,et al.  Exercise Performance During the First Two Years After Left Ventricular Assist Device Implantation , 2017, ASAIO journal.

[18]  C. de Bisschop,et al.  Sit-to-stand tests for COPD: A literature review. , 2017, Respiratory medicine.

[19]  P. Alvarez,et al.  Exercise And Heart Failure: Advancing Knowledge And Improving Care. , 2016, Methodist DeBakey cardiovascular journal.

[20]  P. Ponikowski,et al.  Exercise programs for LVAD supported patients: A snapshot from the ESC affiliated countries. , 2015, International journal of cardiology.

[21]  D. Zimpfer,et al.  Safety and efficacy of cardiac rehabilitation for patients with continuous flow left ventricular assist devices , 2015, European journal of preventive cardiology.

[22]  Ross Arena,et al.  Exercise physiology, testing, and training in patients supported by a left ventricular assist device. , 2015, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[23]  F. Gustafsson,et al.  Exercise in heart failure patients supported with a left ventricular assist device. , 2015, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[24]  S. Keteyian,et al.  Cardiac rehabilitation improves functional capacity and patient-reported health status in patients with continuous-flow left ventricular assist devices: the Rehab-VAD randomized controlled trial. , 2014, JACC. Heart failure.

[25]  Thierry Troosters,et al.  An official European Respiratory Society/American Thoracic Society technical standard: field walking tests in chronic respiratory disease , 2014, European Respiratory Journal.

[26]  H. Katus,et al.  Minimal important difference for 6-minute walk test distances among patients with chronic heart failure. , 2014, International journal of cardiology.

[27]  M. Kohler,et al.  Association between peripheral muscle strength, exercise performance, and physical activity in daily life in patients with Chronic Obstructive Pulmonary Disease , 2014, Multidisciplinary Respiratory Medicine.

[28]  Guy A. MacGowan,et al.  Effect of Left Ventricular Assist Device Implantation and Heart Transplantation on Habitual Physical Activity and Quality of Life☆ , 2014, The American journal of cardiology.

[29]  F. Bellotto,et al.  Exercise performance of chronic heart failure patients in the early period of support by an axial-flow left ventricular assist device as destination therapy. , 2014, Artificial organs.

[30]  W. Kremers,et al.  Usefulness of the six-minute walk test after continuous axial flow left ventricular device implantation to predict survival. , 2012, The American journal of cardiology.

[31]  Luc Vanhees,et al.  Clinical Recommendations for Cardiopulmonary Exercise Testing Data Assessment in Specific Patient Populations , 2012, Circulation.

[32]  S. Russell,et al.  Advanced heart failure treated with continuous-flow left ventricular assist device. , 2009, The New England journal of medicine.

[33]  A. Cohen-Solal,et al.  Standards for the use of cardiopulmonary exercise testing for the functional evaluation of cardiac patients: a report from the Exercise Physiology Section of the European Association for Cardiovascular Prevention and Rehabilitation , 2009, European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology.

[34]  L. Miller,et al.  Patient selection for left-ventricular assist devices , 2009, Current opinion in cardiology.

[35]  J. Spertus,et al.  Development and evaluation of the Kansas City Cardiomyopathy Questionnaire: a new health status measure for heart failure. , 2000, Journal of the American College of Cardiology.

[36]  R. Snaith,et al.  The Hospital Anxiety And Depression Scale , 2003, Health and quality of life outcomes.

[37]  K. Sandau,et al.  A conceptual definition of quality of life with a left ventricular assist device: results from a qualitative study. , 2014, Heart & lung : the journal of critical care.

[38]  M. Gnemmi,et al.  Cardiovascular prevention and rehabilitation for patients with ventricular assist device from exercise therapy to long-term therapy. Part I: Exercise therapy. , 2011, Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace.